| Market revenue in 2024 | USD 971.8 million |
| Market revenue in 2030 | USD 1,728.4 million |
| Growth rate | 10.1% (CAGR from 2025 to 2030) |
| Largest segment | Genomics |
| Fastest growing segment | Epigenetics |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Epigenetics, Proteomics, Metabolomics, Genomics |
| Key market players worldwide | Illumina Inc, Qiagen NV, NeoGenomics Inc, Bruker Corp, Guardant Health Inc, Foundation Medicine |
Publish Date: Jan 11, 2025
Last Updated: Aug 26, 2026
No credit card required*
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Illumina Inc | View profile | 9,300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | www.illumina.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| Guardant Health Inc | View profile | 1,779 | 3100 Hanover Street, Palo Alto, CA, United States, 94304 | www.guardanthealth.com |
| Bruker Corp | View profile | 9,707 | 40 Manning Road, Billerica, MA, United States, 01821 | www.bruker.com |
| Foundation Medicine | View profile | 251-500 | Cambridge, Massachusetts, United States, North America | www.foundationmedicine.com |
| NeoGenomics Inc | View profile | 2,100 | 9490 NeoGenomics Way, Fort Myers, FL, United States, 33912 | www.neogenomics.com |
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Tumor Profiling Market Outlook will help companies and investors design strategic landscapes.
Genomics was the largest segment with a revenue share of 41.81% in 2024.
Horizon Databook has segmented the Germany tumor profiling market based on epigenetics, proteomics, metabolomics, genomics covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany Tumor Profiling Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Germany Tumor Profiling Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.